Abbreviated Breast MRI After Cancer Treatment (NCT03664778) | Clinical Trial Compass
CompletedNot Applicable
Abbreviated Breast MRI After Cancer Treatment
United States184 participantsStarted 2018-09-07
Plain-language summary
500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. status post primary breast cancer treated with breast conservation therapy 3 years prior to recruitment 2. negative DBT examination six months prior to recruitment 3. all breast densities 4. clinically asymptomatic - no palpable masses, focalthickening, or clinically significant discharge We will identify these patients EPIC database utilizing the date of their last mammogram. The patients will be sent a letter explaining the study and the opportunity to enroll in the study. Interested patients may contact our research coordinators by the phone number provided in the letter. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.
Who can participate
Age range18 Years – 82 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Status post primary breast cancer (both invasive and DCIS) treated with breast conservation therapy at least three years prior to recruitment
✓. Negative DBT examination within six months prior to recruitment
✓. All breast densities
✓. Clinically asymptomatic - no palpable masses or focal thickening, etc.
Exclusion criteria
✕. Patients who are pregnant or lactating.
✕. Patients who have not had a mammogram (digital breast tomosynthesis) in the past 6 months.
✕. Patients who are unwilling or unable to provide written informed consent.
✕. Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, etc.).
✕. Recent breast surgery in the past two years including breast enhancements (e.g. implants or injections) benign surgical biopsies.